Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Other Non-Current Assets (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Other Non-Current Assets data on record, last reported at $3.2 million in Q4 2025.

  • For Q4 2025, Other Non-Current Assets changed N/A year-over-year to $3.2 million; the TTM value through Dec 2025 reached $3.2 million, changed N/A, while the annual FY2024 figure was $911000.0, 88.66% down from the prior year.
  • Other Non-Current Assets reached $3.2 million in Q4 2025 per PAHC's latest filing, up from $615000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $86.5 million in Q1 2022 and bottomed at $615000.0 in Q3 2025.
  • Average Other Non-Current Assets over 5 years is $15.7 million, with a median of $6.2 million recorded in 2022.
  • Peak YoY movement for Other Non-Current Assets: soared 941.04% in 2021, then plummeted 91.83% in 2022.
  • A 5-year view of Other Non-Current Assets shows it stood at $5.2 million in 2021, then surged by 44.72% to $7.6 million in 2022, then crashed by 68.69% to $2.4 million in 2023, then tumbled by 61.59% to $911000.0 in 2024, then skyrocketed by 256.75% to $3.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $3.2 million in Q4 2025, $615000.0 in Q3 2025, and $3.9 million in Q1 2025.